Interestingly, 50% of patients who reported anaphylaxis after receiving the first mRNA COVID-19 vaccine had positive test results, indicating that allergy testing might help to identify potential risks in patients with a history of immediate IgE-mediated reactions. This evidence concerns the gene IGHE and allergic disease.